(FBP) First Bancorp - Overview
Stock: Mortgages, Consumer Loans, Commercial Loans, Deposits, Treasury
| Risk 5d forecast | |
|---|---|
| Volatility | 29.1% |
| Relative Tail Risk | -10.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.51 |
| Alpha | -1.10 |
| Character TTM | |
|---|---|
| Beta | 0.805 |
| Beta Downside | 1.252 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.87% |
| CAGR/Max DD | 0.98 |
EPS (Earnings per Share)
Revenue
Description: FBP First Bancorp February 27, 2026
First Bancorp (NYSE: FBP) is the holding company for FirstBank Puerto Rico, delivering a full suite of banking services across six operating segments: Mortgage Banking; Consumer (Retail) Banking; Commercial and Corporate Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. The firm originated, sold, and serviced residential mortgages, offered consumer credit products such as auto loans and credit cards, provided commercial real-estate financing, managed investment funds, and maintained deposit-taking activities in both Puerto Rico and the U.S. mainland.
In its most recent quarter (Q4 2025), First Bancorp reported total assets of $23.5 billion, a 5 % year-over-year increase in its loan portfolio, and a net interest margin of 3.1 %. Net income rose to $120 million, translating to earnings per share of $0.68 and a return on equity of 9.2 %, while deposits grew 4 % and the company maintained a quarterly dividend of $0.16 per share.
Key drivers for the bank include Puerto Rico’s modest GDP expansion of roughly 2.5 % in 2025, which supports consumer and commercial loan demand, and the broader U.S. regional-bank environment where the Federal Reserve’s higher policy rates have lifted NIMs but also heightened credit-quality scrutiny. Additionally, the gradual decline in mortgage rates from their 2023 peaks is easing pressure on the Mortgage Banking segment’s origination volumes.
For a deeper dive, you might explore the ValueRay platform for additional analysis.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 344.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.30 > 1.0 |
| NWC/Revenue: -389.4% < 20% (prev -928.5%; Δ 539.1% < -1%) |
| CFO/TA 0.02 > 3% & CFO 438.1m > Net Income 344.9m |
| Net Debt (290.0m) to EBITDA (433.2m): 0.67 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (158.4m) vs 12m ago -4.34% < -2% |
| Gross Margin: 72.48% > 18% (prev 0.71%; Δ 7177 % > 0.5%) |
| Asset Turnover: 6.43% > 50% (prev 6.18%; Δ 0.25% > 0%) |
| Interest Coverage Ratio: 1.22 > 6 (EBITDA TTM 433.2m / Interest Expense TTM 254.2m) |
Altman Z'' -1.04
| A: -0.25 (Total Current Assets 737.5m - Total Current Liabilities 5.55b) / Total Assets 19.13b |
| B: 0.12 (Retained Earnings 2.27b / Total Assets 19.13b) |
| C: 0.02 (EBIT TTM 309.4m / Avg Total Assets 19.21b) |
| D: 0.11 (Book Value of Equity 1.94b / Total Liabilities 17.17b) |
| Altman-Z'' Score: -1.04 = CCC |
Beneish M
| DSRI: none (Receivables none/71.9m, Revenue 1.24b/1.19b) |
| GMI: 0.98 (GM 72.48% / 70.74%) |
| AQI: 1.38 (AQ_t 0.95 / AQ_t-1 0.69) |
| SGI: 1.04 (Revenue 1.24b / 1.19b) |
| TATA: -0.00 (NI 344.9m - CFO 438.1m) / TA 19.13b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of FBP shares?
Over the past week, the price has changed by -5.54%, over one month by -7.60%, over three months by +5.27% and over the past year by +15.77%.
Is FBP a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FBP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 24.6 | 17.6% |
| Analysts Target Price | 24.6 | 17.6% |
FBP Fundamental Data Overview March 01, 2026
P/S = 3.6478
P/B = 1.8119
P/EG = 0.86
Revenue TTM = 1.24b USD
EBIT TTM = 309.4m USD
EBITDA TTM = 433.2m USD
Long Term Debt = 290.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 290.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 290.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.63b USD (3.34b + Debt 290.0m - (null CCE))
Interest Coverage Ratio = 1.22 (Ebit TTM 309.4m / Interest Expense TTM 254.2m)
EV/FCF = 8.44x (Enterprise Value 3.63b / FCF TTM 429.5m)
FCF Yield = 11.84% (FCF TTM 429.5m / Enterprise Value 3.63b)
FCF Margin = 34.76% (FCF TTM 429.5m / Revenue TTM 1.24b)
Net Margin = 27.91% (Net Income TTM 344.9m / Revenue TTM 1.24b)
Gross Margin = 72.48% ((Revenue TTM 1.24b - Cost of Revenue TTM 340.1m) / Revenue TTM)
Gross Margin QoQ = 73.36% (prev 72.96%)
Tobins Q-Ratio = 0.19 (Enterprise Value 3.63b / Total Assets 19.13b)
Interest Expense / Debt = 21.51% (Interest Expense 62.4m / Debt 290.0m)
Taxrate = 18.85% (20.2m / 107.3m)
NOPAT = 251.1m (EBIT 309.4m * (1 - 18.85%))
Current Ratio = 0.13 (Total Current Assets 737.5m / Total Current Liabilities 5.55b)
Debt / Equity = 0.15 (Debt 290.0m / totalStockholderEquity, last quarter 1.97b)
Debt / EBITDA = 0.67 (Net Debt 290.0m / EBITDA 433.2m)
Debt / FCF = 0.68 (Net Debt 290.0m / FCF TTM 429.5m)
Total Stockholder Equity = 1.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.79% (Net Income 344.9m / Total Assets 19.13b)
RoE = 18.37% (Net Income TTM 344.9m / Total Stockholder Equity 1.88b)
RoCE = 14.28% (EBIT 309.4m / Capital Employed (Equity 1.88b + L.T.Debt 290.0m))
RoIC = 11.62% (NOPAT 251.1m / Invested Capital 2.16b)
WACC = 9.92% (E(3.34b)/V(3.63b) * Re(9.26%) + D(290.0m)/V(3.63b) * Rd(21.51%) * (1-Tc(0.19)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.86%
[DCF] Terminal Value 72.32% ; FCFF base≈407.9m ; Y1≈429.9m ; Y5≈505.6m
[DCF] Fair Price = 38.95 (EV 6.39b - Net Debt 290.0m = Equity 6.10b / Shares 156.6m; r=9.92% [WACC]; 5y FCF grow 5.89% → 2.90% )
EPS Correlation: 84.52 | EPS CAGR: 8.15% | SUE: 0.97 | # QB: 12
Revenue Correlation: 90.46 | Revenue CAGR: 10.02% | SUE: 2.65 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.53 | Chg7d=-0.001 | Chg30d=+0.017 | Revisions Net=+4 | Analysts=7
EPS current Year (2026-12-31): EPS=2.16 | Chg7d=+0.020 | Chg30d=+0.057 | Revisions Net=+3 | Growth EPS=+6.8% | Growth Revenue=+6.4%
EPS next Year (2027-12-31): EPS=2.36 | Chg7d=+0.036 | Chg30d=+0.059 | Revisions Net=+2 | Growth EPS=+9.1% | Growth Revenue=+4.5%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.4% (Discount Rate 9.3% - Earnings Yield 9.7%)
[Growth] Growth Spread = +7.2% (Analyst 6.8% - Implied -0.4%)